We are live on !
Find out more
Moors & Cabot Portfolio holdings
AUM
$2.57B
Turnover
12.7%
1-Year Est. Return
37.84%
Moors & Cabot is a full-service wealth management firm that dates to 1890, when John F. Moors and Charles Cabot started it in Boston. The two founders set it up to manage their own families' investments and those of their friends. It offers investment management, planning and advice for major life events, and runs its own insurance and annuities department. Michael Hildreth, its president and chief executive, is also one of its owners.
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+37.84%
3 Year Est. Return
+124.17%
5 Year Est. Return
+158.09%
10 Year Est. Return
+485.17%
AUM
$569M
AUM Growth
+$15.1M
(+2.7%)
Cap. Flow
-$11.2M
Cap. Flow % of AUM
Cap. Flow %
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
18.45%
Holding
573
New
53
Increased
231
Reduced
180
Closed
56
Avg Time Held
Equity + Options
1.6
years
Top 10 Avg Time Held
Equity + Options
1.8
years
Top 20 Avg Time Held
Equity + Options
1.7
years
Avg Time Held Equity only
1.6
years
Top 10 Avg Time Held Equity only
1.8
years
Top 20 Avg Time Held Equity only
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WestRock Company
WRK
|
+$1.48M |
| 2 |
SHPG
Shire pic
SHPG
|
+$1.37M |
| 3 |
Psychemedics Corporation
PMD
|
+$1.26M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$993K |
| 5 |
Boeing
BA
|
+$955K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$7.82M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$3.49M |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$2.71M |
| 4 |
Under Armour
UAA
|
+$2.01M |
| 5 |
DWA
DREAMWORKS ANIMATION SKG INC CL-A
DWA
|
+$1.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 17.54% |
| 2 | Healthcare | 14.98% |
| 3 | Industrials | 11.31% |
| 4 | Consumer Staples | 10.57% |
| 5 | Miscellaneous | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
GE Aerospace
GE
$313B
| $13.3M | 2.34% |
88,688
+1,912
| +2% | +$279K |
2014 Q1
9 quarters
|
|
2
Johnson & Johnson
JNJ
$658B
| $13.1M | 2.31% |
108,553
-3,732
| -3% | -$424K |
2014 Q1
9 quarters
|
|
3
ExxonMobil
XOM
$764B
| $13.1M | 2.31% |
140,284
-43
| -0% | -$3.8K |
2014 Q1
9 quarters
|
|
4
Procter & Gamble
PG
$374B
| $11M | 1.94% |
130,384
-3,430
| -3% | -$282K |
2014 Q1
9 quarters
|
|
5
AT&T
T
$144B
| $10.9M | 1.91% |
333,191
+10,940
| +3% | +$326K |
2014 Q1
9 quarters
|
|
6
Enterprise Products Partners
EPD
$82.4B
| $10.6M | 1.86% |
361,375
-2,110
| -0.6% | -$56.6K |
2014 Q1
9 quarters
|
|
7
Verizon
VZ
$185B
| $10.2M | 1.79% |
182,800
+11,943
| +7% | +$619K |
2014 Q1
9 quarters
|
|
8
PepsiCo
PEP
$187B
| $8.11M | 1.42% |
76,491
-82
| -0.1% | -$8.46K |
2014 Q1
9 quarters
|
|
9
BP
BP
$130B
| $7.33M | 1.29% |
244,637
+31,233
| +15% | +$842K |
2014 Q1
9 quarters
|
|
|
10
Apple
AAPL
$5.03T
| $7.28M | 1.28% |
303,820
-314,836
| -51% | -$7.82M |
2014 Q1
9 quarters
|
|
|
11
DELISTED
Psychemedics Corporation
PMD
| $6.57M | 1.15% |
479,067
+90,359
| +23% | +$1.26M |
2014 Q1
9 quarters
|
|
12
Chevron
CVX
$459B
| $6.28M | 1.1% |
60,045
+505
| +0.8% | +$50.8K |
2014 Q1
9 quarters
|
|
13
Pfizer
PFE
$174B
| $6.19M | 1.09% |
184,899
-3,357
| -2% | -$107K |
2014 Q1
9 quarters
|
|
|
MMP
14
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $5.99M | 1.05% |
78,821
+455
| +0.6% | +$32.3K |
2014 Q1
9 quarters
|
|
15
Intel
INTC
$350B
| $5.3M | 0.93% |
161,499
-10,558
| -6% | -$331K |
2014 Q1
9 quarters
|
|
16
CVS Health
CVS
$115B
| $4.87M | 0.86% |
50,781
+2,861
| +6% | +$285K |
2014 Q1
9 quarters
|
|
17
Walt Disney
DIS
$192B
| $4.59M | 0.81% |
46,847
-5,164
| -10% | -$516K |
2014 Q1
9 quarters
|
|
18
Microsoft
MSFT
$3.88T
| $4.55M | 0.8% |
88,922
+10,720
| +14% | +$557K |
2014 Q1
9 quarters
|
|
19
Merck
MRK
$369B
| $4.49M | 0.79% |
81,344
+359
| +0.4% | +$19.1K |
2014 Q1
9 quarters
|
|
|
ETP
20
DELISTED
Energy Transfer Partners L.p.
ETP
| $4.43M | 0.78% |
116,315
-780
| -0.7% | -$27.9K |
2014 Q1
9 quarters
|
|
21
Coca-Cola
KO
$405B
| $4.42M | 0.78% |
97,351
+2,760
| +3% | +$125K |
2014 Q1
9 quarters
|
|
22
Bristol-Myers Squibb
BMY
$128B
| $4.28M | 0.75% |
58,155
+2,453
| +4% | +$173K |
2014 Q1
9 quarters
|
|
23
RTX Corp
RTX
$270B
| $4.26M | 0.75% |
65,843
+31
| +0% | +$1.98K |
2014 Q1
9 quarters
|
|
24
Colgate-Palmolive
CL
$75.7B
| $4.17M | 0.73% |
57,053
-9,095
| -14% | -$648K |
2014 Q1
9 quarters
|
|
25
Eaton
ETN
$144B
| $4.09M | 0.72% |
68,520
-76
| -0.1% | -$4.67K |
2014 Q1
9 quarters
|
|
Similar funds
CL
Moors & Cabot's Q2 2016 Portfolio in Review
As of Q2 2016, Moors & Cabot held 573 positions worth $569M, up 2.7% from $554M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Moors & Cabot's Q2 2016 filing shows 53 new, 231 increased, 180 reduced and 56 closed positions. Its largest new stake was WestRock Company: 39,399 shares worth $1.53M. The largest sale was Apple, an estimated $7.82M.
By sector, the portfolio is most concentrated in Energy at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.
- Moors & Cabot's largest Q2 2016 buy was WestRock Company: 39,399 shares worth $1.53M.
- Moors & Cabot added most to Psychemedics Corporation in Q2 2016, an estimated $1.26M increase.
- Moors & Cabot's biggest Q2 2016 reduction was Apple, cutting an estimated $7.82M.
- Moors & Cabot fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $2.71M.
- Moors & Cabot's ten largest holdings make up 18% of its $569M portfolio in Q2 2016.
- Moors & Cabot opened 53 new positions and closed 56 in Q2 2016.
- Moors & Cabot's portfolio value rose 2.7% quarter-over-quarter to $569M.
Based on Moors & Cabot's 13F filing for Q2 2016, filed 8 Aug 2016.